Home›Stock Screener›Yatharth Hospital›Intrinsic Value

Yatharth Hospital Intrinsic Value

Yatharth Hospital intrinsic value. Yatharth Hospital (YATHARTH) median intrinsic value is ₹300.90 from 9 valuation models (range ₹201–₹502), vs current price ₹1003.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Yatharth Hospital stock price NSE.

Market Price (CMP)
₹1003.00
Primary Intrinsic Value
₹300.90
Market Cap
₹9629 Cr
-70.0% Downside
Median Value
₹300.90
Value Range
₹201 - ₹502
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

YATHARTH Valuation Methods Summary — DCF, Graham Number & P/E

Yatharth Hospital intrinsic value across 9 models vs current price ₹1003.00 — upside/downside and value range per method. Compare with Yatharth Hospital valuation methods to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹300.90 ₹240.72 - ₹361.08 -70.0% EPS: ₹19.72, Sector P/E: 12x
Book Value Method asset ₹200.60 ₹180.54 - ₹220.66 -80.0% Book Value/Share: ₹188.23, P/B: 1.0x
Revenue Multiple Method revenue ₹300.90 ₹270.81 - ₹330.99 -70.0% Revenue/Share: ₹145.42, P/S: 0.8x
EBITDA Multiple Method earnings ₹401.20 ₹361.08 - ₹441.32 -60.0% EBITDA: ₹348.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹401.20 ₹320.96 - ₹481.44 -60.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹300.90 ₹270.81 - ₹330.99 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹300.90 ₹270.81 - ₹330.99 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹501.50 ₹451.35 - ₹551.65 -50.0% ROE: 10.0%, P/E Multiple: 10x
Graham Defensive Method conservative ₹300.90 ₹270.81 - ₹330.99 -70.0% EPS: ₹19.72, BVPS: ₹188.23
Method Types: Earnings Asset DCF Growth Dividend Conservative

YATHARTH Intrinsic Value vs Market Price — All Valuation Models

Yatharth Hospital fair value range ₹201–₹502 vs current market price ₹1003.00 across 9 valuation models. Read Yatharth Hospital dividend payments for the complete payout history and dividend yield track record.

YATHARTH Intrinsic Value Analysis — Undervalued or Overvalued?

Yatharth Hospital median intrinsic value ₹300.90, current price ₹1003.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of YATHARTH?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Yatharth Hospital (YATHARTH) is ₹300.90 (median value). With the current market price of ₹1003.00, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹200.60 to ₹501.50, indicating ₹200.60 - ₹501.50.

Is YATHARTH undervalued or overvalued?

Based on our multi-method analysis, Yatharth Hospital (YATHARTH) appears to be trading above calculated value by approximately 70.0%.

YATHARTH Financial Health — Key Ratios vs Industry Benchmarks

Yatharth Hospital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.45 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 10.0% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 23.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.61x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

YATHARTH Cash Flow Quality — Operating & Free Cash Flow

Yatharth Hospital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹205 Cr ₹-94 Cr Positive Operating Cash Flow 6/10
March 2025 ₹131 Cr ₹-63 Cr Positive Operating Cash Flow 6/10
March 2024 ₹-3 Cr ₹-116 Cr Negative Cash Flow 3/10
March 2023 ₹64 Cr ₹54 Cr Positive Free Cash Flow 8/10
March 2022 ₹60 Cr ₹34 Cr Positive Free Cash Flow 8/10